Common osteoporosis drug associated with increased rates of depression and anxiety

Osteoporosis affects over 10 million Americans over 50. Bisphosphonate therapy, mainly alendronate, is amongst the most prescribed treatments for the disease. The use of alendronate and other bisphosphonates has been associated with depressive symptoms in recent case reports. In this study we quanti...

Descripción completa

Detalles Bibliográficos
Autores principales: Keshishi, Dro, Makunts, Tigran, Abagyan, Ruben
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8671447/
https://www.ncbi.nlm.nih.gov/pubmed/34907232
http://dx.doi.org/10.1038/s41598-021-03214-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8671447/
https://www.ncbi.nlm.nih.gov/pubmed/34907232
http://dx.doi.org/10.1038/s41598-021-03214-x

Ejemplares similares